Serotonin and fluoxetine receptors are expressed in enamel organs and LS8 cells and modulate gene expression in LS8 cells

European Journal of Oral Sciences

Volumn 118, Issue 6, 2010, Pages 566-573

  Riksen, Elisabeth A ^a   Stunes, Astrid K ^b   Kalvik, Anne ^a   Gustafsson, Björn I ^b,c   Snead, Malcolm L ^d   Syversen, Unni ^b,c   Lyngstadaas, Ståle P ^a   Reseland, Janne E ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Ameloblasts; Enamel; Fluoxetine; Serotonin

Indexed keywords

ALKALINE PHOSPHATASE; AMBN PROTEIN, MOUSE; AMELOGENIN; CCL2 PROTEIN, MOUSE; ENAMEL PROTEIN; FLUOXETINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; LACTATE DEHYDROGENASE; MATRIX METALLOPROTEINASE 20; MMP20 PROTEIN, MOUSE; MONOCYTE CHEMOTACTIC PROTEIN 1; SEROTONIN; SEROTONIN AGONIST; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SLC6A4 PROTEIN, MOUSE; TPH1 PROTEIN, MOUSE; TRYPTOPHAN HYDROXYLASE; TUFTELIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

AMELOBLAST; ANIMAL; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BAGG ALBINO MOUSE; CELL LINE; COMPARATIVE STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; DRUG EFFECT; GENE EXPRESSION REGULATION; MOUSE; TOOTH FLORA;

ALKALINE PHOSPHATASE; AMELOBLASTS; AMELOGENIN; ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE; CHEMOKINE CCL2; CHEMOKINE CXCL10; CULTURE MEDIA; DENTAL ENAMEL PROTEINS; ENAMEL ORGAN; FLUOXETINE; GENE EXPRESSION REGULATION; L-LACTATE DEHYDROGENASE; MATRIX METALLOPROTEINASE 20; MICE; MICE, INBRED BALB C; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN RECEPTOR AGONISTS; SEROTONIN UPTAKE INHIBITORS; SPECTROPHOTOMETRY, ATOMIC; TRYPTOPHAN HYDROXYLASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78649587521     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/j.1600-0722.2010.00778.x     Document Type: Article

References (36)

1. Addis A, Koren G. Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies. Psychol Med 2000; 30: 89-94.
2. Bairy KL, Madhyastha S, Ashok KP, Bairy I, Malini S. Developmental and behavioral consequences of prenatal fluoxetine. Pharmacology 2007; 79: 1-11.
3. Gustafsson BI, Thommesen L, Stunes AK, Tommeras K, Westbroek I, Waldum HL, Slordahl K, Tamburstuen MV, Reseland JE, Syversen U. Serotonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem 2006; 98: 139-151.
4. Vestergaard P, Rejnmark L, Mosekilde L. Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture. Calcif Tissue Int 2008; 82: 92-101.
5. Moiseiwitsch JR, Raymond JR, Tamir H, Lauder JM. Regulation by serotonin of tooth-germ morphogenesis and gene expression in mouse mandibular explant cultures. Arch Oral Biol 1998; 43: 789-800.
6. Gustafsson BI, Westbroek I, Waarsing JH, Waldum H, Solligard E, Brunsvik A, Dimmen S, Van Leeuwen JP, Weinans H, Syversen U. Long-term serotonin administration leads to higher bone mineral density, affects bone architecture, and leads to higher femoral bone stiffness in rats. J Cell Biochem 2006; 97: 1283-1291.
7. Moiseiwitsch JR, Lauder JM. Regulation of gene expression in cultured embryonic mouse mandibular mesenchyme by serotonin antagonists. Anat Embryol (Berl) 1997; 195: 71-78.
8. Moiseiwitsch JR. The role of serotonin and neurotransmitters during craniofacial development. Crit Rev Oral Biol Med 2000; 11: 230-239.
9. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
10. Chen LS, Couwenhoven RI, Hsu D, Luo W, Snead ML. Maintenance of amelogenin gene expression by transformed epithelial cells of mouse enamel organ. Arch Oral Biol 1992; 37: 771-778.
11. Zhou YL, Snead ML. Identification of CCAAT/enhancer-binding protein alpha as a transactivator of the mouse amelogenin gene. J Biol Chem 2000; 275: 12273-12280.
12. Dhamija S, Liu Y, Yamada Y, Snead ML, Krebsbach PH. Cloning and characterization of the murine ameloblastin promoter. J Biol Chem 1999; 274: 20738-20743.
13. Sharma R, Tsuchiya M, Bartlett JD. Fluoride induces endoplasmic reticulum stress and inhibits protein synthesis and secretion. Environ Health Perspect 2008; 116: 1142-1146.
14. Wang H, Tannukit S, Zhu D, Snead ML, Paine ML. Enamel matrix protein interactions. J Bone Miner Res 2005; 20: 1032-1040.
15. Paine ML, Snead ML, Wang HJ, Abuladze N, Pushkin A, Liu W, Kao LY, Wall SM, Kim YH, Kurtz I. Role of NBCe1 and AE2 in secretory ameloblasts. J Dent Res 2008; 87: 391-395.
16. Zhou YL, Lei Y, Snead ML. Functional antagonism between Msx2 and CCAAT/enhancer-binding protein alpha in regulating the mouse amelogenin gene expression is mediated by protein-protein interaction. J Biol Chem 2000; 275: 29066-29075.
17. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5HT receptors. Pharmacol Biochem Behav 2002; 71: 533-554.
18. O'Sullivan M, Tipton KF, McDevitt WE. Immunolocalization of semicarbazide-sensitive amine oxidase in human dental pulp and its activity towards serotonin. Arch Oral Biol 2002; 47: 399-406.
19. Mina M, Kollar EJ. The induction of odontogenesis in non-dental mesenchyme combined with early murine mandibular arch epithelium. Arch Oral Biol 1987; 32: 123-127.
20. Lumsden AG. Spatial organization of the epithelium and the role of neural crest cells in the initiation of the mammalian tooth germ. Development 1988; 103: 155-169.
21. Sharpe PT. Neural crest and tooth morphogenesis. Adv Dent Res 2001; 15: 4-7.
22. Bolo NR, Hode Y, Macher JP. Long-term sequestration of fluorinated compounds in tissues after fluvoxamine or fluoxetine treatment: a fluorine magnetic resonance spectroscopy study in vivo. MAGMA 2004; 16: 268-276.
23. Warden SJ, Robling AG, Sanders MS, Bliziotes MM, Turner CH. Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 2005; 146: 685-693.
24. Weintrob N, Cohen D, Klipper-Aurbach Y, Zadik Z, Dickerman Z. Decreased growth during therapy with selective serotonin reuptake inhibitors. Arch Pediatr Adolesc Med 2002; 156: 696-701.
25. Moradian-Oldak J. Amelogenins: assembly, processing and control of crystal morphology. Matrix Biol 2001; 20: 293-305.
26. Ten Cate AR. Development of the dentofacial complex. Dent Clin North Am 1982; 26: 445-459.
27. Essner R, Rhoades K, McBride WH, Morton DL, Economou JS. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol 1989; 142: 3857-3861.
28. Feldman ED, Weinreich DM, Carroll NM, Burness ML, Feldman AL, Turner E, Xu H, Alexander HR Jr. Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells. Ann Surg Oncol 2006; 13: 125-133.
29. Mastrangelo F, Piccirilli M, Dolci M, Tete S, Speranza L, Patruno A, Gizzi F, Felaco M, Artese L, De Lutiis MA. Vascular endothelial growth factor (VEGF) in human tooth germ center. Int J Immunopathol Pharmacol 2005; 18: 587-594.
30. Aida M, Irie T, Aida T, Tachikawa T. Expression of protein kinases C betaI, betaII, and VEGF during the differentiation of enamel epithelium in tooth development. J Dent Res 2005; 84: 234-239.
31. Wise GE, Que BG, Huang H. Synthesis and secretion of MCP-1 by dental follicle cells--implications for tooth eruption. J Dent Res 1999; 78: 1677-1681.
32. Omata N, Yasutomi M, Yamada A, Iwasaki H, Mayumi M, Ohshima Y. Monocyte chemoattractant protein-1 selectively inhibits the acquisition of CD40 ligand-dependent IL-12-producing capacity of monocyte-derived dendritic cells and modulates Th1 immune response. J Immunol 2002; 169: 4861-4866.
33. Que BG, Wise GE. Colony-stimulating factor-1 and monocyte chemotactic protein-1 chemotaxis for monocytes in the rat dental follicle. Arch Oral Biol 1997; 42: 855-860.
34. Silva IH, Leao JC, Evencio LB, Porter SR, De Castro RM. Morphological analysis of the enamel organ in rats treated with fluoxetine. Clinics (Sao Paulo) 2010; 65: 61-65.
35. Shuey DL, Sadler TW, Lauder JM. Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors. Teratology 1992; 46: 367-378.
36. Shuey DL, Sadler TW, Tamir H, Lauder JM. Serotonin and morphogenesis. Transient expression of serotonin uptake and binding protein during craniofacial morphogenesis in the mouse. Anat Embryol 1993; 187: 75-85.